Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - topiramate 50mg;  ;   - capsule - 50 mg - active: topiramate 50mg     excipient: cellulose acetate gelatin opacode black s-1-17822 opacode black s-1-17823 povidone sucrose - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Izraelis - anglų - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 25 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Izraelis - anglų - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 50 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Izraelis - anglų - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 100 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Izraelis - anglų - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 200 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

direct rx - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 50 mg - 9.1 controlled substance topiramate is not a controlled substance. 9.2 abuse the abuse and dependence potential of topiramate has not been evaluated in human studies. 9.3 dependence topiramate has not been systematically studied in animals or humans for its potential for tolerance or physical dependence. 8.1 pregnancy pregnancy category d [see warnings and precautions (5.7)] topiramate can cause fetal harm when administered to a pregnant woman. data from pregnancy registries indicate that infants exposed to topiramate in utero have an increased risk for cleft lip and/or cleft palate (oral clefts). when multiple species of pregnant animals received topiramate at clinically relevant doses, structural malformations, including craniofacial defects, and reduced fetal weights occurred in offspring. topiramate should be used during pregnancy only if the potential benefit outweighs the potential risk. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - topiramate -

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - topiramate -

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

johnson & johnson sdn bhd - topiramate -

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - topiramate 300mg;   - film coated tablet - 300 mg - active: topiramate 300mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry as opadry red ys-1-1759-g sodium starch glycolate starch